Summary:
A Vutrisiran Sodium (25㎎ 0.5㎖/Syringe) 3 Syringes,B Elapegademase (Genetical Recombination) (2.4㎎ 1.5㎖/Vial) 22 Vials,C Atezolizumab (Genetical Recombination) (1200㎎ 20.0㎖/Vial) 35 Vials,D Pembrolizumab (Genetical Recombination) (100. Country:
Japan
Notice Type:
Tender Notice Deadline:
09 Apr 2024 Posting Date:
26 Mar 2024 |
Summary:
Infusion Pump And Syringe Pump 1 Set Country:
Japan
Notice Type:
Tender Notice Deadline:
26 Mar 2024 Posting Date:
11 Mar 2024 |